Crescent Pharma recalls Ramipril 2.5mg due to packaging error
Crescent Pharma Limited is recalling Ramipril 2.5mg capsules due to a packaging error that may lead to patients receiving the incorrect dosage.
Asset / Drug
Drug and asset intelligence for Crescent with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
ACE Inhibitor
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.